Company: SOS
Filing Date: 2025-07-31
Form Type: 424B5
Source: 0001213900-25-069766
Chunk: 31

Company: SOS Ltd
Filing Date: 2025-07-31
Form: 424B5
Chunk 31
---
 in China and its management
on offerings conducted overseas by, and foreign investment in, China-based issuers could limit our and our PRC subsidiaries’ ability
to conduct business and/or limit or hinder our ability to offer or continue to offer securities to investors, accept foreign investments
or list on a United States or other foreign exchange, or cause the value of our securities to significantly decline or be worthless. For
more details, see “Risk Factors—Risks Related to Doing Business in China.”

Our ADSs are listed on the New York Stock
Exchange (the “NYSE”), under the symbol “SOS.” On June 24, 2025, the closing trading price for our ADSs, as reported
on NYSE, was US$5.89 per ADS.

Pursuant to General Instruction I.B.5. of
Form F-3, in no event will we sell the securities covered hereby in a public primary offering with a value exceeding more than one-third
of the aggregate market value of our ordinary shares in any 12-month period so long as the aggregate market value of our issued and outstanding
ordinary shares held by non-affiliates remains below US$75,000,000. The aggregate market value of our issued and outstanding Class A
ordinary shares held by non-affiliates, or public float, as of June 25, 2025, was approximately US$45.8 million, which was calculated
based on 991,316,492 Class A ordinary shares held by non-affiliates and the per ADS price of US$6.93, which was the closing price
of our ADSs onMay 12, 2025. During the 12 calendar months prior to and including the date of this prospectus, we have not offered or
sold any securities pursuant to General Instruction I.B.5 of Form F-3.

Each time we sell these securities, we will provide a supplement to
this prospectus that contains specific information about the offering and the terms of the securities offered. The supplement may also
add, update or change information contained in this prospectus. You should carefully read this prospectus and any prospectus supplement
before you invest in any of these securities.

We may offer and sell the securities from time to time at fixed prices,
at market prices or at negotiated prices, to or through underwriters, to other purchasers, through agents, or through a combination of
these methods, on a continuous or delayed basis. See “Plan of Distribution.”